| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NEUROCRINE BIOSCIE COM USD0.001 | 305,630 | 13,891,000 | 9.12% | ||
| 2 | SEATTLE GENETICS INC | 328,430 | 13,272,000 | 8.72% | ||
| 3 | MEAD JOHNSON NUTRITION CO | 135,045 | 12,255,000 | 8.05% | ||
| 4 | BIOMARIN | 152,253 | 11,845,000 | 7.78% | ||
| 5 | MASIMO CORP COM | 218,960 | 11,499,000 | 7.55% | ||
| 6 | ABIOMED INC | 104,920 | 11,467,000 | 7.53% | ||
| 7 | BOSTON SCIENTIFIC CORP | 469,900 | 10,982,000 | 7.21% | ||
| 8 | VERTEX PHARMACEUT | 125,450 | 10,791,000 | 7.09% | ||
| 9 | IRONWOOD PHARMACEUTICALS INC COM CL A | 821,070 | 10,735,000 | 7.05% | ||
| 10 | MOLINA HEALTHCARE INC | 205,270 | 10,243,000 | 6.73% | ||
| 11 | BIOGEN INC | 40,000 | 9,673,000 | 6.35% | ||
| 12 | NUVASIVE INC COM | 159,660 | 9,535,000 | 6.26% | ||
| 13 | ALLERGAN PLC | 36,940 | 8,536,000 | 5.61% | ||
| 14 | SHIRE PLC | 41,060 | 7,558,000 | 4.96% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-118828, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
